1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Genomic Testing in Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Breast Cancer 1.2.3 Lung Cancer 1.2.4 Blood Cancer 1.2.5 Liver Cancer 1.2.6 Stomach Cancer 1.2.7 Others 1.3 Market by Application 1.3.1 Global Genomic Testing in Cancer Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 General Hospitals 1.3.3 Specialty Clinics 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Genomic Testing in Cancer Market Perspective (2018-2029) 2.2 Genomic Testing in Cancer Growth Trends by Region 2.2.1 Global Genomic Testing in Cancer Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Genomic Testing in Cancer Historic Market Size by Region (2018-2023) 2.2.3 Genomic Testing in Cancer Forecasted Market Size by Region (2024-2029) 2.3 Genomic Testing in Cancer Market Dynamics 2.3.1 Genomic Testing in Cancer Industry Trends 2.3.2 Genomic Testing in Cancer Market Drivers 2.3.3 Genomic Testing in Cancer Market Challenges 2.3.4 Genomic Testing in Cancer Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Genomic Testing in Cancer Players by Revenue 3.1.1 Global Top Genomic Testing in Cancer Players by Revenue (2018-2023) 3.1.2 Global Genomic Testing in Cancer Revenue Market Share by Players (2018-2023) 3.2 Global Genomic Testing in Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Genomic Testing in Cancer Revenue 3.4 Global Genomic Testing in Cancer Market Concentration Ratio 3.4.1 Global Genomic Testing in Cancer Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Genomic Testing in Cancer Revenue in 2022 3.5 Genomic Testing in Cancer Key Players Head office and Area Served 3.6 Key Players Genomic Testing in Cancer Product Solution and Service 3.7 Date of Enter into Genomic Testing in Cancer Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Genomic Testing in Cancer Breakdown Data by Type 4.1 Global Genomic Testing in Cancer Historic Market Size by Type (2018-2023) 4.2 Global Genomic Testing in Cancer Forecasted Market Size by Type (2024-2029) 5 Genomic Testing in Cancer Breakdown Data by Application 5.1 Global Genomic Testing in Cancer Historic Market Size by Application (2018-2023) 5.2 Global Genomic Testing in Cancer Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Genomic Testing in Cancer Market Size (2018-2029) 6.2 North America Genomic Testing in Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Genomic Testing in Cancer Market Size by Country (2018-2023) 6.4 North America Genomic Testing in Cancer Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Genomic Testing in Cancer Market Size (2018-2029) 7.2 Europe Genomic Testing in Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Genomic Testing in Cancer Market Size by Country (2018-2023) 7.4 Europe Genomic Testing in Cancer Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Genomic Testing in Cancer Market Size (2018-2029) 8.2 Asia-Pacific Genomic Testing in Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Genomic Testing in Cancer Market Size by Region (2018-2023) 8.4 Asia-Pacific Genomic Testing in Cancer Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Genomic Testing in Cancer Market Size (2018-2029) 9.2 Latin America Genomic Testing in Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Genomic Testing in Cancer Market Size by Country (2018-2023) 9.4 Latin America Genomic Testing in Cancer Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Genomic Testing in Cancer Market Size (2018-2029) 10.2 Middle East & Africa Genomic Testing in Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Genomic Testing in Cancer Market Size by Country (2018-2023) 10.4 Middle East & Africa Genomic Testing in Cancer Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 23andMe 11.1.1 23andMe Company Detail 11.1.2 23andMe Business Overview 11.1.3 23andMe Genomic Testing in Cancer Introduction 11.1.4 23andMe Revenue in Genomic Testing in Cancer Business (2018-2023) 11.1.5 23andMe Recent Development 11.2 Agilent Technologies 11.2.1 Agilent Technologies Company Detail 11.2.2 Agilent Technologies Business Overview 11.2.3 Agilent Technologies Genomic Testing in Cancer Introduction 11.2.4 Agilent Technologies Revenue in Genomic Testing in Cancer Business (2018-2023) 11.2.5 Agilent Technologies Recent Development 11.3 Bio-Rad Laboratories 11.3.1 Bio-Rad Laboratories Company Detail 11.3.2 Bio-Rad Laboratories Business Overview 11.3.3 Bio-Rad Laboratories Genomic Testing in Cancer Introduction 11.3.4 Bio-Rad Laboratories Revenue in Genomic Testing in Cancer Business (2018-2023) 11.3.5 Bio-Rad Laboratories Recent Development 11.4 Centogene 11.4.1 Centogene Company Detail 11.4.2 Centogene Business Overview 11.4.3 Centogene Genomic Testing in Cancer Introduction 11.4.4 Centogene Revenue in Genomic Testing in Cancer Business (2018-2023) 11.4.5 Centogene Recent Development 11.5 Color Genomics 11.5.1 Color Genomics Company Detail 11.5.2 Color Genomics Business Overview 11.5.3 Color Genomics Genomic Testing in Cancer Introduction 11.5.4 Color Genomics Revenue in Genomic Testing in Cancer Business (2018-2023) 11.5.5 Color Genomics Recent Development 11.6 Gene By Gene 11.6.1 Gene By Gene Company Detail 11.6.2 Gene By Gene Business Overview 11.6.3 Gene By Gene Genomic Testing in Cancer Introduction 11.6.4 Gene By Gene Revenue in Genomic Testing in Cancer Business (2018-2023) 11.6.5 Gene By Gene Recent Development 11.7 Illumina 11.7.1 Illumina Company Detail 11.7.2 Illumina Business Overview 11.7.3 Illumina Genomic Testing in Cancer Introduction 11.7.4 Illumina Revenue in Genomic Testing in Cancer Business (2018-2023) 11.7.5 Illumina Recent Development 11.8 LabCorp 11.8.1 LabCorp Company Detail 11.8.2 LabCorp Business Overview 11.8.3 LabCorp Genomic Testing in Cancer Introduction 11.8.4 LabCorp Revenue in Genomic Testing in Cancer Business (2018-2023) 11.8.5 LabCorp Recent Development 11.9 Myriad Genetics 11.9.1 Myriad Genetics Company Detail 11.9.2 Myriad Genetics Business Overview 11.9.3 Myriad Genetics Genomic Testing in Cancer Introduction 11.9.4 Myriad Genetics Revenue in Genomic Testing in Cancer Business (2018-2023) 11.9.5 Myriad Genetics Recent Development 11.10 Positive Bioscience 11.10.1 Positive Bioscience Company Detail 11.10.2 Positive Bioscience Business Overview 11.10.3 Positive Bioscience Genomic Testing in Cancer Introduction 11.10.4 Positive Bioscience Revenue in Genomic Testing in Cancer Business (2018-2023) 11.10.5 Positive Bioscience Recent Development 11.11 Quest Diagnostics 11.11.1 Quest Diagnostics Company Detail 11.11.2 Quest Diagnostics Business Overview 11.11.3 Quest Diagnostics Genomic Testing in Cancer Introduction 11.11.4 Quest Diagnostics Revenue in Genomic Testing in Cancer Business (2018-2023) 11.11.5 Quest Diagnostics Recent Development 11.12 Thermo Fisher Scientific 11.12.1 Thermo Fisher Scientific Company Detail 11.12.2 Thermo Fisher Scientific Business Overview 11.12.3 Thermo Fisher Scientific Genomic Testing in Cancer Introduction 11.12.4 Thermo Fisher Scientific Revenue in Genomic Testing in Cancer Business (2018-2023) 11.12.5 Thermo Fisher Scientific Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Genomic Testing in Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Breast Cancer Table 3. Key Players of Lung Cancer Table 4. Key Players of Blood Cancer Table 5. Key Players of Liver Cancer Table 6. Key Players of Stomach Cancer Table 7. Key Players of Others Table 8. Global Genomic Testing in Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 9. Global Genomic Testing in Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 10. Global Genomic Testing in Cancer Market Size by Region (2018-2023) & (US$ Million) Table 11. Global Genomic Testing in Cancer Market Share by Region (2018-2023) Table 12. Global Genomic Testing in Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 13. Global Genomic Testing in Cancer Market Share by Region (2024-2029) Table 14. Genomic Testing in Cancer Market Trends Table 15. Genomic Testing in Cancer Market Drivers Table 16. Genomic Testing in Cancer Market Challenges Table 17. Genomic Testing in Cancer Market Restraints Table 18. Global Genomic Testing in Cancer Revenue by Players (2018-2023) & (US$ Million) Table 19. Global Genomic Testing in Cancer Market Share by Players (2018-2023) Table 20. Global Top Genomic Testing in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Testing in Cancer as of 2022) Table 21. Ranking of Global Top Genomic Testing in Cancer Companies by Revenue (US$ Million) in 2022 Table 22. Global 5 Largest Players Market Share by Genomic Testing in Cancer Revenue (CR5 and HHI) & (2018-2023) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Genomic Testing in Cancer Product Solution and Service Table 25. Date of Enter into Genomic Testing in Cancer Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Genomic Testing in Cancer Market Size by Type (2018-2023) & (US$ Million) Table 28. Global Genomic Testing in Cancer Revenue Market Share by Type (2018-2023) Table 29. Global Genomic Testing in Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 30. Global Genomic Testing in Cancer Revenue Market Share by Type (2024-2029) Table 31. Global Genomic Testing in Cancer Market Size by Application (2018-2023) & (US$ Million) Table 32. Global Genomic Testing in Cancer Revenue Market Share by Application (2018-2023) Table 33. Global Genomic Testing in Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 34. Global Genomic Testing in Cancer Revenue Market Share by Application (2024-2029) Table 35. North America Genomic Testing in Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 36. North America Genomic Testing in Cancer Market Size by Country (2018-2023) & (US$ Million) Table 37. North America Genomic Testing in Cancer Market Size by Country (2024-2029) & (US$ Million) Table 38. Europe Genomic Testing in Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 39. Europe Genomic Testing in Cancer Market Size by Country (2018-2023) & (US$ Million) Table 40. Europe Genomic Testing in Cancer Market Size by Country (2024-2029) & (US$ Million) Table 41. Asia-Pacific Genomic Testing in Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 42. Asia-Pacific Genomic Testing in Cancer Market Size by Region (2018-2023) & (US$ Million) Table 43. Asia-Pacific Genomic Testing in Cancer Market Size by Region (2024-2029) & (US$ Million) Table 44. Latin America Genomic Testing in Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 45. Latin America Genomic Testing in Cancer Market Size by Country (2018-2023) & (US$ Million) Table 46. Latin America Genomic Testing in Cancer Market Size by Country (2024-2029) & (US$ Million) Table 47. Middle East & Africa Genomic Testing in Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 48. Middle East & Africa Genomic Testing in Cancer Market Size by Country (2018-2023) & (US$ Million) Table 49. Middle East & Africa Genomic Testing in Cancer Market Size by Country (2024-2029) & (US$ Million) Table 50. 23andMe Company Detail Table 51. 23andMe Business Overview Table 52. 23andMe Genomic Testing in Cancer Product Table 53. 23andMe Revenue in Genomic Testing in Cancer Business (2018-2023) & (US$ Million) Table 54. 23andMe Recent Development Table 55. Agilent Technologies Company Detail Table 56. Agilent Technologies Business Overview Table 57. Agilent Technologies Genomic Testing in Cancer Product Table 58. Agilent Technologies Revenue in Genomic Testing in Cancer Business (2018-2023) & (US$ Million) Table 59. Agilent Technologies Recent Development Table 60. Bio-Rad Laboratories Company Detail Table 61. Bio-Rad Laboratories Business Overview Table 62. Bio-Rad Laboratories Genomic Testing in Cancer Product Table 63. Bio-Rad Laboratories Revenue in Genomic Testing in Cancer Business (2018-2023) & (US$ Million) Table 64. Bio-Rad Laboratories Recent Development Table 65. Centogene Company Detail Table 66. Centogene Business Overview Table 67. Centogene Genomic Testing in Cancer Product Table 68. Centogene Revenue in Genomic Testing in Cancer Business (2018-2023) & (US$ Million) Table 69. Centogene Recent Development Table 70. Color Genomics Company Detail Table 71. Color Genomics Business Overview Table 72. Color Genomics Genomic Testing in Cancer Product Table 73. Color Genomics Revenue in Genomic Testing in Cancer Business (2018-2023) & (US$ Million) Table 74. Color Genomics Recent Development Table 75. Gene By Gene Company Detail Table 76. Gene By Gene Business Overview Table 77. Gene By Gene Genomic Testing in Cancer Product Table 78. Gene By Gene Revenue in Genomic Testing in Cancer Business (2018-2023) & (US$ Million) Table 79. Gene By Gene Recent Development Table 80. Illumina Company Detail Table 81. Illumina Business Overview Table 82. Illumina Genomic Testing in Cancer Product Table 83. Illumina Revenue in Genomic Testing in Cancer Business (2018-2023) & (US$ Million) Table 84. Illumina Recent Development Table 85. LabCorp Company Detail Table 86. LabCorp Business Overview Table 87. LabCorp Genomic Testing in Cancer Product Table 88. LabCorp Revenue in Genomic Testing in Cancer Business (2018-2023) & (US$ Million) Table 89. LabCorp Recent Development Table 90. Myriad Genetics Company Detail Table 91. Myriad Genetics Business Overview Table 92. Myriad Genetics Genomic Testing in Cancer Product Table 93. Myriad Genetics Revenue in Genomic Testing in Cancer Business (2018-2023) & (US$ Million) Table 94. Myriad Genetics Recent Development Table 95. Positive Bioscience Company Detail Table 96. Positive Bioscience Business Overview Table 97. Positive Bioscience Genomic Testing in Cancer Product Table 98. Positive Bioscience Revenue in Genomic Testing in Cancer Business (2018-2023) & (US$ Million) Table 99. Positive Bioscience Recent Development Table 100. Quest Diagnostics Company Detail Table 101. Quest Diagnostics Business Overview Table 102. Quest Diagnostics Genomic Testing in Cancer Product Table 103. Quest Diagnostics Revenue in Genomic Testing in Cancer Business (2018-2023) & (US$ Million) Table 104. Quest Diagnostics Recent Development Table 105. Thermo Fisher Scientific Company Detail Table 106. Thermo Fisher Scientific Business Overview Table 107. Thermo Fisher Scientific Genomic Testing in Cancer Product Table 108. Thermo Fisher Scientific Revenue in Genomic Testing in Cancer Business (2018-2023) & (US$ Million) Table 109. Thermo Fisher Scientific Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Genomic Testing in Cancer Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Genomic Testing in Cancer Market Share by Type: 2022 VS 2029 Figure 3. Breast Cancer Features Figure 4. Lung Cancer Features Figure 5. Blood Cancer Features Figure 6. Liver Cancer Features Figure 7. Stomach Cancer Features Figure 8. Others Features Figure 9. Global Genomic Testing in Cancer Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 10. Global Genomic Testing in Cancer Market Share by Application: 2022 VS 2029 Figure 11. General Hospitals Case Studies Figure 12. Specialty Clinics Case Studies Figure 13. Genomic Testing in Cancer Report Years Considered Figure 14. Global Genomic Testing in Cancer Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 15. Global Genomic Testing in Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 16. Global Genomic Testing in Cancer Market Share by Region: 2022 VS 2029 Figure 17. Global Genomic Testing in Cancer Market Share by Players in 2022 Figure 18. Global Top Genomic Testing in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Testing in Cancer as of 2022) Figure 19. The Top 10 and 5 Players Market Share by Genomic Testing in Cancer Revenue in 2022 Figure 20. North America Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. North America Genomic Testing in Cancer Market Share by Country (2018-2029) Figure 22. United States Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Canada Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. Europe Genomic Testing in Cancer Market Share by Country (2018-2029) Figure 26. Germany Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. France Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. U.K. Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Italy Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Russia Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Nordic Countries Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Asia-Pacific Genomic Testing in Cancer Market Share by Region (2018-2029) Figure 34. China Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Japan Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. South Korea Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Southeast Asia Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. India Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Australia Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Latin America Genomic Testing in Cancer Market Share by Country (2018-2029) Figure 42. Mexico Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Brazil Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Middle East & Africa Genomic Testing in Cancer Market Share by Country (2018-2029) Figure 46. Turkey Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Saudi Arabia Genomic Testing in Cancer Market Size YoY Growth (2018-2029) & (US$ Million) Figure 48. 23andMe Revenue Growth Rate in Genomic Testing in Cancer Business (2018-2023) Figure 49. Agilent Technologies Revenue Growth Rate in Genomic Testing in Cancer Business (2018-2023) Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Genomic Testing in Cancer Business (2018-2023) Figure 51. Centogene Revenue Growth Rate in Genomic Testing in Cancer Business (2018-2023) Figure 52. Color Genomics Revenue Growth Rate in Genomic Testing in Cancer Business (2018-2023) Figure 53. Gene By Gene Revenue Growth Rate in Genomic Testing in Cancer Business (2018-2023) Figure 54. Illumina Revenue Growth Rate in Genomic Testing in Cancer Business (2018-2023) Figure 55. LabCorp Revenue Growth Rate in Genomic Testing in Cancer Business (2018-2023) Figure 56. Myriad Genetics Revenue Growth Rate in Genomic Testing in Cancer Business (2018-2023) Figure 57. Positive Bioscience Revenue Growth Rate in Genomic Testing in Cancer Business (2018-2023) Figure 58. Quest Diagnostics Revenue Growth Rate in Genomic Testing in Cancer Business (2018-2023) Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Genomic Testing in Cancer Business (2018-2023) Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

23andMe Agilent Technologies Bio-Rad Laboratories Centogene Color Genomics Gene By Gene Illumina LabCorp Myriad Genetics Positive Bioscience Quest Diagnostics Thermo Fisher Scientific